160 related articles for article (PubMed ID: 33694231)
1. Clusterin inhibits Aβ
Xu L; Tian S; Peng X; Hua Y; Yang W; Chen L; Liu S; Wu W; Zhao J; He J; Wu L; Yang J; Zheng Y
J Neurochem; 2021 Jul; 158(2):444-454. PubMed ID: 33694231
[TBL] [Abstract][Full Text] [Related]
2. Clusterin Binding Modulates the Aggregation and Neurotoxicity of Amyloid-β(1-42).
Kim YM; Park S; Choi SY; Oh SB; Jung M; Pack CG; Hwang JJ; Tak E; Lee JY
Mol Neurobiol; 2022 Oct; 59(10):6228-6244. PubMed ID: 35904715
[TBL] [Abstract][Full Text] [Related]
3. Kinesin-1 inhibits the aggregation of amyloid-β peptide as detected by fluorescence cross-correlation spectroscopy.
Zheng Y; Tian S; Peng X; Yang J; Fu Y; Jiao Y; Zhao J; He J; Hong T
FEBS Lett; 2016 Apr; 590(7):1028-37. PubMed ID: 26991731
[TBL] [Abstract][Full Text] [Related]
4. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide.
Narayan P; Orte A; Clarke RW; Bolognesi B; Hook S; Ganzinger KA; Meehan S; Wilson MR; Dobson CM; Klenerman D
Nat Struct Mol Biol; 2011 Dec; 19(1):79-83. PubMed ID: 22179788
[TBL] [Abstract][Full Text] [Related]
5. The effects of fluorescent labels on Aβ
Zheng Y; Xu L; Yang J; Peng X; Wang H; Yu N; Hua Y; Zhao J; He J; Hong T
Biopolymers; 2018 Nov; 109(11):e23237. PubMed ID: 30311215
[TBL] [Abstract][Full Text] [Related]
6. Clusterin Binds to Aβ1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation.
Beeg M; Stravalaci M; Romeo M; Carrá AD; Cagnotto A; Rossi A; Diomede L; Salmona M; Gobbi M
J Biol Chem; 2016 Mar; 291(13):6958-66. PubMed ID: 26884339
[TBL] [Abstract][Full Text] [Related]
7. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils.
Cui L; Zhang Y; Cao H; Wang Y; Teng T; Ma G; Li Y; Li K; Zhang Y
J Alzheimers Dis; 2013; 37(1):19-28. PubMed ID: 23727899
[TBL] [Abstract][Full Text] [Related]
8. Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation Spectroscopy.
Guan Y; Cao KJ; Cantlon A; Elbel K; Theodorakis EA; Walsh DM; Yang J; Shah JV
ACS Chem Neurosci; 2015 Sep; 6(9):1503-8. PubMed ID: 26212450
[TBL] [Abstract][Full Text] [Related]
9. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data.
Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA
CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985
[TBL] [Abstract][Full Text] [Related]
11. Iron treatment inhibits Aβ42 deposition in vivo and reduces Aβ42/Aβ40 ratio.
Shen X; Liu J; Fujita Y; Liu S; Maeda T; Kikuchi K; Obara T; Takebe A; Sayama R; Takahashi T; Matsue A; Sera K; Michikawa M; Komano H; Zou K
Biochem Biophys Res Commun; 2019 May; 512(4):653-658. PubMed ID: 30791980
[TBL] [Abstract][Full Text] [Related]
12. [Cell-surface Initial Aggregation Process of Amyloid-β Peptides Studied by Fluorescence Correlation Spectroscopy].
Yano Y
Yakugaku Zasshi; 2021; 141(6):825-829. PubMed ID: 34078789
[TBL] [Abstract][Full Text] [Related]
13. Live Cell FRET Imaging Reveals Amyloid β-Peptide Oligomerization in Hippocampal Neurons.
Gao Y; Wennmalm S; Winblad B; Schedin-Weiss S; Tjernberg LO
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926107
[TBL] [Abstract][Full Text] [Related]
14. Kinetic Insights into Zn
Guo J; Yu L; Sun Y; Dong X
J Phys Chem B; 2017 Apr; 121(16):3909-3917. PubMed ID: 28378589
[TBL] [Abstract][Full Text] [Related]
15. Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
Weiffert T; Meisl G; Flagmeier P; De S; Dunning CJR; Frohm B; Zetterberg H; Blennow K; Portelius E; Klenerman D; Dobson CM; Knowles TPJ; Linse S
ACS Chem Neurosci; 2019 May; 10(5):2374-2384. PubMed ID: 30793584
[TBL] [Abstract][Full Text] [Related]
16. Effective screen for amyloid β aggregation inhibitor using amyloid β-conjugated gold nanoparticles.
Han SH; Chang YJ; Jung ES; Kim JW; Na DL; Mook-Jung I
Int J Nanomedicine; 2010 Dec; 6():1-12. PubMed ID: 21289976
[TBL] [Abstract][Full Text] [Related]
17. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
18. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
19. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
Shuaib S; Goyal B
J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
[TBL] [Abstract][Full Text] [Related]
20. Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Sato M; Murakami K; Uno M; Nakagawa Y; Katayama S; Akagi K; Masuda Y; Takegoshi K; Irie K
J Biol Chem; 2013 Aug; 288(32):23212-24. PubMed ID: 23792961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
